We can hypothesize that the impaired metabolic action of FGF19 in the insulin resistant state may accentuate the effect of low vitamin D concentration on NAFLD, although this has not yet been proven. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.